4.42MMarket Cap
LossP/E TTM
Key Figures
1.900Open
1.920High
9.61KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.41%Turnover Ratio
1.880Prev. Close
1.830Low
9.65KTurnover
LossP/E Static
2.05P/B
0.00%Div Yield TTM
-205.30%ROA
6.20052wk High
0.99Volume Ratio
-4.68MNet Profit
2.35MShares
-1.9896EPS TTM
-1.06Beta
-350.30%ROE
1.67052wk Low
4.79%Amplitude
100.00%Gross Margin
4.42MMarket Cap
-1.85Reward/Risk
5.21%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Alaunos Therapeutics Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 202 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Alaunos Therapeutics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Alaunos Therapeutics Inc Highlights
StrengthsRisks
Alaunos Therapeutics Inc News
More news coming soon, stay tuned...
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Alaunos Therapeutics Inc Info
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.
Ticker SymbolTCRT
CompanyAlaunos Therapeutics Inc
CEOWeis (Holger)
Websitehttps://alaunos.com/
Shareholders
FAQs
What is the current price of Alaunos Therapeutics Inc (TCRT)?
The current price of Alaunos Therapeutics Inc (TCRT) is 1.88.
What is the symbol of Alaunos Therapeutics Inc?
The ticker symbol of Alaunos Therapeutics Inc is TCRT.
What is the 52-week high of Alaunos Therapeutics Inc?
The 52-week high of Alaunos Therapeutics Inc is 6.20.
What is the 52-week low of Alaunos Therapeutics Inc?
The 52-week low of Alaunos Therapeutics Inc is 1.67.
What is the market capitalization of Alaunos Therapeutics Inc?
The market capitalization of Alaunos Therapeutics Inc is 4.42M.
What is the Earnings Per Share (EPS TTM) of Alaunos Therapeutics Inc (TCRT)?
The Earnings Per Share (EPS TTM) of Alaunos Therapeutics Inc (TCRT) is -2.14.
